Related Experiment Video
Updated: Jul 12, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy
Tzu-Chao Chuang1, Jah-Yao Liu, Chi-Tsai Lin
1Department of Chemistry, Tamkang University, Tamsui, Taiwan, ROC. tcbc@mail.tku.edu.tw
Abstract:
The up-regulation of HER2/neu is associated with human malignancies and is a useful target for developing anticancer drugs. Overexpression of human manganese superoxide dismutase (MnSOD) has been demonstrated to effectively suppress various carcinoma cells, including breast carcinomas, in vitro and in vivo. This study demonstrates that MnSOD effectively suppresses HER2/neu oncogene expression at the transcriptional level. Additionally, stable transfection was used and the MnSOD-transfected human breast cancer clones were found to be able to down-regulate the endogenous production of p185(HER2/neu). Furthermore, the MnSOD-overexpressing stable transfectants exhibited reduced soft-agarose colony-forming ability and metastatic properties, unlike control cell lines. These data suggest that MnSOD may be useful in treating HER2/neu-mediated human breast tumor malignancy.
Insights
Manganese superoxide dismutase (MnSOD) overexpression suppresses HER2/neu oncogene expression in breast cancer cells. This finding suggests MnSOD as a potential therapeutic agent for HER2/neu-driven malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- HER2/neu oncogene up-regulation is linked to human cancers, presenting a target for drug development.
- Overexpression of human manganese superoxide dismutase (MnSOD) inhibits carcinoma cell growth in vitro and in vivo.
Purpose of the Study:
- To investigate the effect of MnSOD on HER2/neu oncogene expression.
- To evaluate the therapeutic potential of MnSOD in HER2/neu-mediated breast cancer.
Main Methods:
- Stable transfection of human breast cancer cells with MnSOD.
- Analysis of HER2/neu oncogene expression at the transcriptional level.
- Assessment of colony-forming ability and metastatic properties in MnSOD-overexpressing cells.
Main Results:
- MnSOD suppresses HER2/neu expression transcriptionally.
- MnSOD-transfected cells down-regulated endogenous p185(HER2/neu) production.
- MnSOD overexpression reduced soft-agarose colony formation and metastatic potential.
Conclusions:
- MnSOD effectively inhibits HER2/neu oncogene expression.
- MnSOD demonstrates potential as a therapeutic strategy for HER2/neu-positive breast tumors.
- Further research into MnSOD for cancer therapy is warranted.
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
